Relaxation time of brain tissue in the elderly assessed by synthetic MRI.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
01 2022
Historique:
revised: 12 10 2021
received: 18 03 2021
accepted: 31 10 2021
pubmed: 5 12 2021
medline: 15 3 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

Synthetic MRI (SyMRI) is a quantitative technique that allows measurements of T1 and T2 relaxation times (RTs). Brain RT evolution across lifespan is well described for the younger population. The aim was to study RTs of brain parenchyma in a healthy geriatric population in order to define the normal value of structures in this group population. Normal values for geriatric population could help find biomarker for age-related brain disease. Fifty-four normal-functioning individuals (22 females, 32 males) with mean age of 83 years (range 56-98) underwent SyMRI. RT values in manually defined ROIs (centrum semiovale, middle cerebellar peduncles, thalamus, and insular cortex) and in segmented whole-brain components (brain parenchyma, gray matter, white matter, myelin, CSF, and stromal structures) were extracted from the SyMRI segmentation software. Patients' results were combined into the group age. Main ROI-based and whole-brain results were compared for the all dataset and for age group results as well. For white matter, RTs between ROI-based analyses and whole-brain results for T2 and for T1 were statistically different and a trend of increasing T1 in centrum semiovale and cerebellar peduncle was observed. For gray matter, thalamic T1 was statistically different from insular T1. A difference was also found between left and right insula (p < .0001). T1 RTs of ROI-based and whole-brain-based analyses were statistically different (p < .0001). No significant difference in T1 and T2 was found between age groups on ROI-based analysis, but T1 in centrum semiovale and thalamus increased with age. No statistical difference between age groups was found for the various segmented volumes except for myelin between 65-74 years of age and the 95-105 years of age groups (p = .038). SyMRI is a new tool that allows faster imaging and permits to obtain quantitative T1 and T2. By defining RT values of different brain components of normal-functioning elderly individuals, this technique may be used as a biomarker for clinical disorders like dementia.

Sections du résumé

BACKGROUND
Synthetic MRI (SyMRI) is a quantitative technique that allows measurements of T1 and T2 relaxation times (RTs). Brain RT evolution across lifespan is well described for the younger population. The aim was to study RTs of brain parenchyma in a healthy geriatric population in order to define the normal value of structures in this group population. Normal values for geriatric population could help find biomarker for age-related brain disease.
MATERIALS AND METHODS
Fifty-four normal-functioning individuals (22 females, 32 males) with mean age of 83 years (range 56-98) underwent SyMRI. RT values in manually defined ROIs (centrum semiovale, middle cerebellar peduncles, thalamus, and insular cortex) and in segmented whole-brain components (brain parenchyma, gray matter, white matter, myelin, CSF, and stromal structures) were extracted from the SyMRI segmentation software. Patients' results were combined into the group age. Main ROI-based and whole-brain results were compared for the all dataset and for age group results as well.
RESULTS
For white matter, RTs between ROI-based analyses and whole-brain results for T2 and for T1 were statistically different and a trend of increasing T1 in centrum semiovale and cerebellar peduncle was observed. For gray matter, thalamic T1 was statistically different from insular T1. A difference was also found between left and right insula (p < .0001). T1 RTs of ROI-based and whole-brain-based analyses were statistically different (p < .0001). No significant difference in T1 and T2 was found between age groups on ROI-based analysis, but T1 in centrum semiovale and thalamus increased with age. No statistical difference between age groups was found for the various segmented volumes except for myelin between 65-74 years of age and the 95-105 years of age groups (p = .038).
CONCLUSIONS
SyMRI is a new tool that allows faster imaging and permits to obtain quantitative T1 and T2. By defining RT values of different brain components of normal-functioning elderly individuals, this technique may be used as a biomarker for clinical disorders like dementia.

Identifiants

pubmed: 34862855
doi: 10.1002/brb3.2449
pmc: PMC8785630
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2449

Informations de copyright

© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

AJNR Am J Neuroradiol. 2017 Dec;38(12):2364-2372
pubmed: 28982788
Eur Radiol. 2017 Apr;27(4):1568-1576
pubmed: 27379992
Magn Reson Med. 2009 Jan;61(1):125-35
pubmed: 19097220
J Magn Reson Imaging. 2019 Dec;50(6):1834-1842
pubmed: 30968991
Magn Reson Imaging Clin N Am. 2003 Nov;11(4):641-53
pubmed: 15018115
J Cogn Neurosci. 2013 Sep;25(9):1477-92
pubmed: 23701459
Brain. 1997 Jan;120 ( Pt 1):141-57
pubmed: 9055804
IEEE Trans Med Imaging. 2010 Nov;29(11):1927-41
pubmed: 20570765
Neuroimage. 2006 Apr 1;30(2):359-76
pubmed: 16406816
Neuroimage. 2019 Aug 1;196:276-288
pubmed: 30986501
Eur Radiol. 2012 May;22(5):998-1007
pubmed: 22113264
Magn Reson Imaging. 1997;15(10):1133-43
pubmed: 9408134
Eur J Neurosci. 2015 May;41(11):1438-47
pubmed: 25858359
Nature. 2013 Mar 14;495(7440):187-92
pubmed: 23486058
Magn Reson Imaging. 2017 Jan;35:69-80
pubmed: 27594531
Front Neurol. 2016 Feb 17;7:16
pubmed: 26925030
Insights Imaging. 2015 Apr;6(2):163-5
pubmed: 25800993
MAGMA. 2016 Dec;29(6):833-842
pubmed: 27333937
Brain Behav. 2022 Jan;12(1):e2449
pubmed: 34862855
Early Hum Dev. 2019 Dec;139:104853
pubmed: 31473466
Magn Reson Med. 2015 Dec;74(6):1621-31
pubmed: 25491018
J Magn Reson Imaging. 2005 Jul;22(1):13-22
pubmed: 15971174
Radiology. 1991 Nov;181(2):537-43
pubmed: 1924801
Neuroradiology. 2016 Oct;58(10):1017-1026
pubmed: 27438803
Invest Radiol. 2017 Oct;52(10):647-657
pubmed: 28257339

Auteurs

Martin Ndengera (M)

Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.

Bénédicte M A Delattre (BMA)

Division of Radiology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.

Max Scheffler (M)

Division of Radiology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.

Karl-Olof Lövblad (KO)

Division of Neuroradiology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Torstein R Meling (TR)

Division of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Maria Isabel Vargas (MI)

Division of Neuroradiology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH